Connective Tissue Disease Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Connective Tissue Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

Pulmonary HypertensionConnective Tissue DiseaseAdult Congenital Heart Disease+1 more
Children's Hospital Medical Center, Cincinnati5,000 enrolled1 locationNCT07477197
Recruiting
Phase 2

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

Non-small Cell Lung CancerNSCLCNSCLC Stage II+5 more
Memorial Sloan Kettering Cancer Center25 enrolled7 locationsNCT07323732
Recruiting
Phase 2

129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial HypertensionConnective Tissue DiseasesIdiopathic Pulmonary Arterial Hypertension+1 more
Bastiaan Driehuys20 enrolled1 locationNCT06104228
Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatoid ArthritisLyme DiseaseSarcoidosis+17 more
Yale University5,000 enrolled1 locationNCT04402086
Recruiting
Not Applicable

Creating Health Course Study for People With Rheumatological Conditions

Rheumatoid ArthritisPsoriatic ArthritisSystemic Lupus Erythematosus+2 more
Terry L. Wahls200 enrolled1 locationNCT07180537
Recruiting

Rutgers University Study of the Genetics of Pulmonary Hypertension

Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Arterial Hypertension of Congenital Heart Disease+5 more
Rutgers, The State University of New Jersey10,000 enrolled1 locationNCT07217522
Recruiting

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement

Takayasu Arteritis With Pulmonary Artery InvolvementPulmonary Arterial Hypertension Associated With Connective Tissue Disease
China-Japan Friendship Hospital150 enrolled1 locationNCT07184814
Recruiting

Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography

Connective Tissue Disease (CTD)Interstitial Lung Disease Due to Systemic Disease (Disorder)Idiopathic Pulmonary Fibrosis (IPF)+1 more
Azienda Unita Sanitaria Locale di Piacenza500 enrolled5 locationsNCT07174102
Recruiting

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+10 more
University of Bonn120 enrolled1 locationNCT07150000
Recruiting

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionPulmonary Arterial Hypertension Associated With Connective Tissue Disease
Vanderbilt University Medical Center75 enrolled1 locationNCT05462574
Recruiting
Phase 2

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting

AYLo - AutoimmunitY and Loss of y

Asthma BronchialeCOPDSarcoidosis+10 more
University of Bonn500 enrolled1 locationNCT06696027
Recruiting
Not Applicable

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Rheumatoid ArthritisConnective Tissue DiseasesDermatomyositis+3 more
Oslo University Hospital218 enrolled1 locationNCT06732674
Recruiting

REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)

Pulmonary Arterial HypertensionConnective Tissue Diseases
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran170 enrolled1 locationNCT05665556
Recruiting

New Orleans Pulmonary Hypertension Biobank

HealthyPulmonary HypertensionSystemic Sclerosis+2 more
Louisiana State University Health Sciences Center in New Orleans450 enrolled1 locationNCT03269630